Hjem › Neuroblastom › Hawaii › Honolulu
Neuroblastom kliniske forsøg i Honolulu, HI
6 studier for Neuroblastom søger deltagere på steder i og omkring Honolulu (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Kapiolani Medical Center for Women and Children, Honolulu
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekruttererFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruttererFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Neuroblastom forsøg i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Honolulu
- Kræft (alle typer)13 studier
- Overvægt13 studier
- Brystkræft12 studier
- Overvægt11 studier
- Ikke-småcellet lungecancer10 studier
- Lungecancer8 studier
- Akut myeloid leukæmi7 studier
- Type 2-diabetes7 studier
- Ægstockræft7 studier
- Bugspytkirtelkræft7 studier
- Prostatakræft5 studier
- Burkitts lymfom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.